We are looking for 2–17 years of age to join a UC clinical research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or ulcerative colitis (UC) (including associated symptoms such as diarrhea with blood, growth failure, constant need to poop, malnutrition and/or liver disease), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited so act quickly.
